Improvement of DC vaccine with ALA-PDT induced immunogenic apoptotic cells for skin squamous cell carcinoma

Oncotarget

Volumn 6, Issue 19, 2015, Pages 17135-17146

  Ji, Jie ^a   Fan, Zhixia ^a   Zhou, Feifan ^b   Wang, Xiaojie ^a   Shi, Lei ^a   Zhang, Haiyan ^a   Wang, Peiru ^a   Yang, Degang ^a   Zhang, Linglin ^a   Chen, Wei R ^a,b   Wang, Xiuli ^a  

^a Skin and Cosmetic Research Department   (China)

^b UNIVERSITY OF CENTRAL OKLAHOMA   (United States)

Author keywords

5 aminolevulinic acid; Dendritic cell; Immunogenic apoptosis; PDT DC vaccine; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; CANCER VACCINE; CD86 ANTIGEN; DENDRITIC CELL VACCINE; GAMMA INTERFERON; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHOTOSENSITIZING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL GROWTH; CELL MATURATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PROTEIN EXPRESSION; SKIN CARCINOMA; T LYMPHOCYTE; TREATMENT DURATION; TUMOR IMMUNITY; UPREGULATION; ANIMAL; DENDRITIC CELL; DISEASE MODEL; FLOW CYTOMETRY; IMMUNOLOGY; PATHOLOGY; PHOTOCHEMOTHERAPY; PHYSIOLOGY; PROCEDURES; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TRANSMISSION ELECTRON MICROSCOPY; TRANSPLANTATION;

AMINOLEVULINIC ACID; ANIMALS; APOPTOSIS; CANCER VACCINES; CARCINOMA, SQUAMOUS CELL; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS;

EID: 84938222734     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3529     Document Type: Article

References (47)

1. Chow MT, Möller A, Smyth MJ. Inflammation and immune surveillance in cancer. Semin Cancer Biol. 2012; 22:23-32.
2. Bruyns C, Gérard C, Velu T. Cancer escape from immune surveillance: how can it be overcome by gene transfer? Eur J Cancer. 1994; 30:1176-1181.
3. Peranzoni E, Rivas-Caicedo A, Bougherara H, Salmon H, Donnadieu E. Positive and negative influence of the matrix architecture on antitumor immune surveillance. Cell Mol Life Sci. 2013; 70:4431-4448.
4. Turnis ME, Rooney CM. Enhancement of dendritic cells as vaccines for cancer. Immunotherapy. 2010; 2:847-862.
5. Guilliams M, Ginhoux F, Jakubzick C, Naik SH, Onai N, Schraml BU, Segura E, Tussiwand R, Yona S. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat Rev Immunol. 2014; 14:571-578.
6. Heesters BA, Myers RC, Carroll MC. Follicular dendritic cells: dynamic antigen libraries. Nat Rev Immunol. 2014; 14:495-504.
7. Palucka K, Banchereau J. Cancer immunotherapy via dendritic cells. Nat Rev Cancer. 2012; 12:265-277.
8. Ma Y, Shurin GV, Peiyuan Z, Shurin MR. Dendritic cells in the cancer microenvironment. J Cancer. 2013; 4:36-44.
9. Vopenkova K, Mollova K, Buresova I, Michalek J. Complex evaluation of human monocyte-derived dendritic cells for cancer immunotherapy. J Cell Mol Med. 2012; 16:2827-2837.
10. Morisaki T, Matsumoto K, Onishi H, Kuroki H, Baba E, Tasaki A, Kubo M, Nakamura M, Inaba S, Yamaguchi K, Tanaka M, Katano M. Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancerpatients: rationale, current progress, and perspectives. Hum Cell. 2003; 16:175-182.
11. Nencioni A, Grünebach F, Schmidt SM, Müller MR, Boy D, Patrone F, Ballestrero A, Brossart P. The use of dendritic cells in cancer immunotherapy. Crit Rev Oncol Hematol. 2008; 65:191-199.
12. Huang Z, Xu H, Meyers AD, Musani AI, Wang L, Tagg R, Barqawi AB, Chen YK. Photodynamic therapy for treatment of solid tumors - potential and technical challenges. Technol Cancer Res Treat. 2008; 7:309-320.
13. Wang XL, Wang HW, Wang HS, Xu SZ, Liao KH, Hillemanns P. Topical 5-aminolaevulinic acid-photodynamic therapy for the treatment of urethral condylomata acuminata. Br J Dermatol. 2004; 151:880-885.
14. Castano AP, Mroz P, Hamblin MR. Photodynamic therapy and antitumour immunity. Nat Rev Cancer. 2006; 6:535-545.
15. Korbelik M, Dougherty GJ. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. Cancer Res. 1999; 59:1941-1946.
16. Korbelik M, Sun J. Photodynamic therapy generated vaccine for cancer therapy. Cancer Immunol Immunother. 2004; 55:900-909.
17. Canti G, De Simone A, Korbelik M. Photodynamic therapy and the immune system in experimental oncology. Photochem Photobiol Sci. 2002; 1:79-80.
18. Gollnick SO, Vaughan L, Henderson BW. Generation of effective antitumor vaccines using photodynamic therapy. Cancer Res. 2002; 62:16040-16048.
19. Garg AD, Nowis D, Golab J, Agostinis P. Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity. Apoptosis. 2010; 15:1050-1071.
20. Korbelik M, Sun J. Photodynamic therapy-generated vaccine for cancer therapy. Cancer Immunol Immunother. 2006; 55:900-909.
21. Gollnick SO, Brackett CM. Enhancement of anti-tumor immunity by photodynamic therapy. Immunol Res. 2009; 46:216-226.
22. Jung NC, Kim HJ, Kang MS, Lee JH, Song JY, Seo HG, Bae YS, Lim DS. Photodynamic therapy-mediated DC immunotherapy is highly effective for the inhibition of established solid tumors. Cancer Lett. 2012; 324:58-65.
23. Garg AD, Nowis D, Golab J, Vandenabeele P, Krysko DV, Agostinis P. Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. Biochim Biophys Acta. 2010; 1805:53-71.
24. Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol. 2009; 9:353-363.
25. Zitvogel L, Kepp O, Kroemer G. Decoding cell death signals in inflammation and immunity. Cell. 2010; 140:798-804.
26. Zitvogel L, Kepp O, Senovilla L, Menger L, Chaput N, Kroemer G. Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway. Clin Cancer Res. 2010; 16:3100-3104.
27. Zhou F, Xing D, Chen WR. Regulation of HSP70 on activating macrophages using PDT-induced apoptotic cells. Int J Cancer. 2009; 125:1380-1389.
28. Garg AD, Krysko DV, Verfaillie T, Kaczmarek A, Ferreira GB, Marysael T, Rubio N, Firczuk M, Mathieu C, Roebroek AJ, Annaert W, Golab J, de Witte P, et al. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J. 2012; 31:1062-1067.
29. Garg AD, Krysko DV, Vandenabeele P, Agostinis P. Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin. Cancer Immunol Immunother. 2012; 61:215-221.
30. Ratushny V, Gober MD, Hick R, Ridky TW, Seykora JT. From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest. 2012; 122:464-472.
31. Wang XL, Wang HW, Guo MX, Xu SZ. Treatment of skin cancer and pre-cancer using topical ALA-PDT - a single hospital experience. Photodiagnosis Photodyn Ther. 2008; 5:127-133.
32. Shixiang Y, Xi S, Junliang L, Shanyi Z, Xingke X, Meiguang Z, Kai W, Fangcheng L. Antitumor efficacy of a photodynamic therapy-generated dendritic cell glioma vaccine. Med Oncol. 2011; 28:453-461.
33. Liu Z, Fan H, Wu Y, Chen B. Potent in vivo anti-tumor activity of isolated CD62L (low) lymph node cells sensitized in vivo with tumor lysate-pulsed DC-based vaccines. Cytotherapy. 2005; 7:353-362.
34. Hirschowitz EA, Foody T, Kryscio R, Dickson L, Sturgill J, Yannelli J. Autologous dendritic cell vaccines for non-small-cell lung cancer. J Clin Oncol. 2004; 22:2808-2815.
35. Chen WR, Adams RL, Carubelli R, Nordquist RE. Laser-photosensitizer assisted immunotherapy: A novel modality in cancer treatment. Cancer Lett. 1997; 115:25-30.
36. Chen WR, Singhal AK, Liu H, Nordquist RE. Laser immunotherapy induced antitumor immunity and its adoptive transfer. Cancer Res. 2001; 61:459-461.
37. Chen WR, Liu H, Ritchey JW, Bartels KE, Lucroy MD, Nordquist RE. Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats. Cancer Res. 2002; 62:4295-4299.
38. Li X, Naylor MF, Le H, Nordquist RE, Teague TK, Howard CA, Murray C, Chen WR. Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients: Apreliminary study. Cancer Biol Ther. 2010; 10:1081-1087.
39. Li X, Ferrel GL, Guerra MC, Hode T, Lunn JA, Adalsteinsson O, Nordquist RE, Liu H, Chen WR. Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients. Photochem Photobiol Sci. 2011; 10:817-821.
40. Shi L, Wang XL, Zhao F, Luan HS, Tu QF, Huang Z, Wang H, Wang HW. In vitro evaluation of 5-aminolevulinic acid (ALA) loaded PLGA nanoparticles. Int J Nanomed. 2013; 8:2669-2676.
41. Wang HW, Li JJ, Lv T, Tu QF, Huang Z, Wang XL. Therapeutic and immune effects of 5-aminolevulinic acid photodynamic therapy on UVB-induced squamous cell carcinomas in hairless mice. Exp Dermatol. 2013; 22:262-263.
42. Lang K, Bolsen K, Stahl W. The 5-aminolevulinic acid-induced porphyrin biosynthesis in benign and malignant cells of the skin. J Photochem Photobiol B. 2001; 65:29-34.
43. Chung CW, Kim CH, Choi KH, Yoo JJ, Kim do H, Chung KD, Jeong YI, Kang DH. Effect of surfactant on 5-aminole-vulinic acid uptake and PpIX generation in human cholangiocarcinoma cell. Eur J Pharm Biopharm. 2012; 80:453-458.
44. Grundy M, Seedhouse C, Russell NH, Pallis M. P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the aurora-B kinase inhibitor barasertib-hQPA. BMC Cancer. 2011; 11:254.
45. Mullins CS, Eisold S, Klar E, Linnebacher M. Multidrug-resistance proteins are weak tumor associated antigens for colorectal carcinoma. BMC Immunol. 2011; 12:38.
46. Cvetanovic M, Ucker DS. Innate immune discrimination of apoptotic cells: repression of proinflammatory macrophage transcription is coupled directly to specific recognition. J Immunol. 2004; 172:880-889.
47. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage Colony-stimulating factor. J Exp Med. 1992; 176:1693-1702.